The stock fell from the ascending channel and met its target and got overdone a bit more...chief reason was low realiations of its main product Ibuprofen... it has many more products and is in Crams as well which lent it some support...1st target is 1380 with SL at 1150 levels.. some days it has low trading volumes as well ...its like an insurance in ones portfolio against covid if one wants to think like that... buyer beware